ARC REGULATORY LIMITED
Company number NI601946 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£948,393
Balance sheet as at 2025-01-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2010-01-28
- Employees
- 24 (2025 accounts · was 17 in 2024)
- Registered office
- Unit 1, Concourse Building 2 Catalyst, Queens Road, Belfast, Northern Ireland, BT3 9DT
- Postcode
- BT3 9DT
- Capital
- 4 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-01-31
- Next due by
- 2026-10-31
- Financial year end
- 31 January
Confirmation statement
- Last statement dated
- 2026-02-09
- Next due by
- 2027-02-23
Nature of business (SIC)
- 74909 Other professional, scientific and technical activities not elsewhere classified
Officers 2 current
Group structure
Controlled by JAVA HOLDINGS LTD — since 2023-12-19
From persons-with-significant-control filings on the public register.
Contact details
- Website
- arc-regulatory.com
- Phone
- 03031231113
ARC Regulatory - your clinical research & regulatory compliance solutions partner, precision medicine, CDx & IVD medical device industry.
Previous company names
| Name | Date changed |
|---|---|
| ADVANCE REGULATORY CONSULTING LIMITED | 2018-03-21 |
| SEAMUS KEARNEY LIMITED | 2014-02-06 |
Previous registered addresses 1
| Address | Changed on |
|---|---|
| 63 BALLYGROOBY ROAD, MONEYMORE, MAGHERAFELT, BT45 7XD | 2018-12-03 |
Among its peers
Top 10%
by shareholders' funds, of 557 similar companies in BT
Among the biggest employers among its local peers (24 staff).
Among the oldest 25% of its local peers, trading since 2010.
Competitors Belfast
-
1. XABIS LTD
This company ranks 28 among other professional, scientific and technical activities not elsewhere classified in Belfast.
The class of 2010
26%
of the 6,236 companies in this sector incorporated in 2010 are still active today; 72% have since been dissolved.
A fact about the year, not a forecast for this company.